R are genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend ...

CRISPR Therapeutics could stage a comeback thanks to clinical and commercial progress. There are many promising corporations ...

The gene-editing platform known as Crispr is widely used by researchers in scientific laboratories in their search for new ...

UConn Health and Connecticut Children's have made history by dosing the first patient in a clinical trial using gene editing to treat glycogen storage ...

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

PROTEUS, a system designed to harness “directed evolution,” can speed the process up by years, or even decades.

The PROTEUS system uses biological artificial intelligence to evolve molecules within mammalian cells, enhancing gene ...

Fourteen million people worldwide suffer from enlarged hearts, or hypertrophic cardiomyopathy (HCM), a genetic disease that ...

"Field tests showed significantly higher yields." Officials make game-changing announcement that could flood grocery shelves ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...